Dr. Shiqi Wang is a Docent (Adjunct Professor) and Principal Investigator at the Faculty of Pharmacy, University of Helsinki. Her research focuses on the fundamental understanding and development of nanoparticles for intracellular drug delivery (http://www.helsinki.fi/intracellular-drug-delivery).

Short Biography

Dr. Wang obtained her BSc and MSc in chemistry from the Department of Chemistry Tsinghua University (China). In 2018, she obtained her PhD from Imperial College London (UK) with exceptional merits, and then joined the University of Helsinki, Faculty of Pharmacy as a Postdoctoral Fellow in Prof. Hélder Santos' group. In 2022, Dr. Wang got the Title of Docent in Pharmaceutical Nanotechnology, and in 2023, the Faculty of Pharmacy appointed her as the Principal Investigator.

Dr. Shiqi Wang has several ongoing projects funded by the Research Council of Finland (former Acadmy of Finland), Sigrid Jusélius Foundation, Finnish Red Cross Blood Service Research Fund, and Jane and Aatos Erkko Foundation. In 2023, Dr. Wang received the ERC starting grant of 1.5 M€, to develop innovative solutions for intracellular drug delivery quantification.